Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
Sponsor: Health Sciences North Research Institute
A PHASE4 clinical study on Elderly Immune System, this trial is ongoing. The trial is conducted by Health Sciences North Research Institute and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE4
-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
▶ Show 6 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Aug 2018 — Mar 2020 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Mar 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Health Sciences North Research Institute
- UConn Health
For direct contact, visit the study record on ClinicalTrials.gov .